Physician profile
Corinne Mccullion
NPI 1598320756
$1,649.17
in general payments reported to CMS, 2019-2025
21 companies · $690 in 2025
The $690 reported for 2025 was more than what 77% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $150 · 2022: $261 · 2023: $170 · 2024: $377 · 2025: $690.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,237.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $150.91 | 2025 | Nemluvio |
| Janssen Scientific Affairs, LLC | $136.30 | 2025 | Tremfya |
| Arcutis Biotherapeutics, INC. | $127.84 | 2025 | Zoryve |
| Boston Scientific Corporation | $127.65 | 2022-2024 | Watchman Access System, Watchman Flx |
| Organon LLC | $127.45 | 2025 | Vtama |
| Genzyme Corporation | $124.98 | 2024 | |
| Verrica Pharmaceuticals INC. | $124.15 | 2024 | Ycanth |
| Sun Pharmaceutical Industries INC. | $116.62 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $105.85 | 2024 | Spevigo |
| Ucb, INC. | $95.03 | 2023 | Bimzelx |
| Amgen INC. | $84.30 | 2021-2022 | |
| Amarin Pharma, INC. | $83.88 | 2021-2022 | |
| Philips North America LLC | $46.15 | 2022-2023 | |
| Leo Pharma INC. | $31.12 | 2025 | Anzupgo |
| Pfizer INC. | $29.64 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $29.43 | 2022 | |
| Esperion Therapeutics, INC. | $27.40 | 2022 | |
| Abiomed | $25.49 | 2021 | |
| Astellas Pharma US INC | $19.44 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.70 | 2022 | |
| Merck Sharp & Dohme LLC | $16.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corinne Mccullion listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.